Insmed Incorporated(INSM)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
INSM | 22.22 B | - | 296.10% | -76.94% | -$4.06 | -87.22% | 0.98x | 0.00% | $212.75 | $90.39 |
NTRA | 57.02 B | - | 37.70% | -7.11% | -$1.35 | -12.54% | 0.13x | 0.00% | $427.47 | $157.43 |
RVMD | 43.05 B | - | - | 0.00% | -$8.86 | -79.09% | 0.46x | 0.00% | $224.31 | $45.60 |
BIIB | 32.82 B | 40.03x | 3.40% | 8.32% | $5.55 | 4.58% | 0.44x | 0.00% | $230.49 | $138.00 |
ALNY | 30.03 B | 41.63x | 66.90% | 16.13% | $5.39 | 96.56% | 2.21x | 0.00% | $495.55 | $197.81 |
Peer Valuation & Performance Analysis
Peer group analysis for Insmed Incorporated (INSM) compared to its primary competitors (including NTRA, RVMD, BIIB) reveals distinct metrics. INSM trades at a valuation premium compared to its competitors, with a P/E ratio of -25.1x versus the peer average of -58.5x (representing a -57% premium). This indicates that the market expects superior growth or commands a quality premium for INSM. In terms of growth, INSM's revenue growth of 296.1% exceeds the peer average of 36.0%, highlighting its competitive strength and market share gains. Additionally, its net margin of -76.9% is below the peer average of 4.3%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• INSM ranks #0 in P/E ratio, #1 in revenue growth, and #5 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $103.87 | $104.80 | $101.60 | $101.74 | 3,164,000 | -3.32% |
| 2026-10-06 | $103.97 | $107.87 | $101.32 | $105.23 | 3,685,700 | +1.35% |
| 2026-10-05 | $105.50 | $108.75 | $101.65 | $103.83 | 5,394,700 | -6.56% |
| 2026-10-02 | $107.76 | $111.54 | $105.68 | $111.12 | 4,136,200 | +2.33% |
| 2026-10-01 | $114.68 | $116.19 | $108.48 | $108.59 | 2,646,300 | -4.86% |
| 2026-09-30 | $115.65 | $116.43 | $113.60 | $114.14 | 2,868,400 | -1.29% |
| 2026-09-29 | $117.06 | $118.50 | $114.49 | $115.63 | 1,668,200 | -1.73% |
| 2026-09-28 | $116.83 | $119.32 | $116.31 | $117.67 | 1,744,400 | -0.14% |
| 2026-09-25 | $121.87 | $122.90 | $115.87 | $117.83 | 2,672,700 | -3.06% |
| 2026-09-24 | $119.26 | $121.69 | $118.38 | $121.55 | 2,233,600 | +2.71% |
| 2026-09-23 | $121.58 | $122.65 | $116.74 | $118.34 | 1,921,600 | -2.05% |
| 2026-09-22 | $121.00 | $122.48 | $119.09 | $120.82 | 2,405,300 | -0.15% |
| 2026-09-21 | $123.06 | $124.48 | $120.92 | $121.00 | 1,811,900 | +0.83% |
| 2026-09-18 | $123.89 | $124.11 | $119.32 | $120.00 | 3,443,200 | -3.21% |
| 2026-09-17 | $124.16 | $127.40 | $122.88 | $123.98 | 1,591,800 | +1.14% |
Explore More Analysis for INSM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.